Trial Profile
A Phase 1 Study of [14C]-MLN9708 to Assess Mass Balance, Pharmacokinetics, and Metabolism in Patients With Advanced Solid Tumors or Lymphomas
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2013
Price :
$35
*
At a glance
- Drugs Ixazomib (Primary)
- Indications Lymphoma; Solid tumours
- Focus Pharmacokinetics
- 05 Aug 2013 New trial record